Dr Reddy's Laboratories is poised to expand its OTC offering in Russia and the Commonwealth of Independent States by acquiring a basket of allergy treatments from Glenmark Pharmaceuticals. The transaction is subject to the completion of certain precedent actions and closing activities.
Through the deal, Hyderabad-based Dr Reddy’s will gain the following brands, along with trademark, dossiers and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?